Valuing health technologies at nice: rec
โ
Dana Goldman; Darius Lakdawalla; Tomas J. Philipson; Wesley Yin
๐
Article
๐
2010
๐
John Wiley and Sons
๐
English
โ 98 KB
Pricing, reimbursements and coverage decisions for medical innovations and services are complex. In many countries, valuing medical technologies is the responsibility of national health-care systems that strive for distributive efficiency under fiscal constraints on medical spending. In the UK, the